Taurine effects on the occurrence of cardiac arrhythmias and QT interval dispersion in patients with postinfarction cardiosclerosis and chronic heart failure: a comparative randomised study

Taurine effects on the occurrence of cardiac arrhythmias and QT interval dispersion in patients with postinfarction cardiosclerosis and chronic heart failure: a comparative randomised study

Aim. To study the effects of taurine therapy on the occurrence of cardiac arrhythmias and QT interval dispersion (dQT) among patients with postinfarction cardiosclerosis (PICS) and subsequent chronic heart failure (CHF). Material and methods. The study included 40 patients with previous myocardial i...

Full description

Bibliographic Details
Main Authors:	I. G. Gordeev, E. M. Pokrovskaya, E. E. Luchinkina
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2012-02-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	хроническая сердечная недостаточность таурин дисперсия интервала qt нарушения ритма сердца
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/1701

Similar Items

QT and QTa interval duration and dispersion during stress test in coronary heart disease and ventricular arrhythmia patients
by: N. V. Furman, et al.
Published: (1970-01-01)

EFFECTS OF SYMPATHOMIMETIC AGENTS ON ELECTROCARDIOGRAM INDEXES IN PATIENTS WITH BRONCHIAL ASTHMA
by: I. G. Fomina, et al.
Published: (2015-12-01)

Sinus arrhythmia effects on QT dispersion parameters in healthy individuals and coronary heart disease patients
by: P. Ya. Dovgalevsky, et al.
Published: (1970-01-01)

Prognostic value of high-resolution electrocardiography parameters, heart rate variability, and QT interval dynamics in patients with chronic heart failure
by: A. E. Radzevich, et al.
Published: (2006-08-01)

HEART RATE AND QT VARIABILITY IN PATIENTS WITH METABOLIC SYNDROME COMPLICATED BY CARDIAC ARRHYTHMIA
by: E. D. Dzhishambaev, et al.
Published: (2012-06-01)

Heart rate variability in patients with chronic rheumatic heart disease
by: V. S. Petrov
Published: (2019-11-01)

Study of Heart Rate Variability in Patients with Chronic Heart Failure and Chronic Obstructive Pulmonary Disease
by: M. E. Statsenko, et al.
Published: (2021-08-01)

Taurine effects on 24-hour blood pressure monitoring parameters in patients with chronic heart failure and metabolic syndrome
by: I. V. Kryuchkova, et al.
Published: (1970-01-01)

Molecular genetic markers of QT interval duration and sudden cardiac death: literature review
by: A. M. Nesterets, et al.
Published: (2022-04-01)

Endothelium protecting properties of taurin in chronic heart failure with type 2 diabetes
by: M. E. Stacenko, et al.
Published: (2016-04-01)

MANAGEMENT OF PATIENTS WITH RHEUMATIC HEART DISEASES AND CHRONIC HEART FAILURE
by: Aleksey Nikolayevich Kalyagin
Published: (2009-09-01)

РИСК РАЗВИТИЯ ФИБРИЛЛЯЦИИ ПРЕДСЕРДИЙ И РОЛЬ ОЦЕНКИ СТАНДАРТНОЙ ЭКГ С ПОЗИЦИИ ДИСПЕРСИОННОГО АНАЛИЗА ЗУБЦА Р И ИНТЕРВАЛА PQ
Published: (2006-12-01)

Rational pharmacotherapy of chronic obstructive pulmonary disease in elderly patients with cardiac arrhythmias: the role of a betaadrenoblocker bisoprolol
by: D. A. Kadaeva, et al.
Published: (2010-10-01)

OMEGA-3 POLYUNSATURATED FATTY ACIDS IN THE TREATMENT OF PATIENTS WITH CARDIOVASCULAR DISEASES
by: A. V. Govorin, et al.
Published: (2015-12-01)

Prognostic role of metabolic risk factors (hyperhomocysteinemia) in the development of chronic heart failure
by: Е. Н. Березикова, et al.
Published: (2015-10-01)

Relation of the heart remodeling and endothelial dysfunction in chronic heart failure patients
by: Ch. A. Abdullaeva, et al.
Published: (2016-02-01)

Trimetazidine MB treatment in patients with chronic heart failure
by: T. E. Morozova, et al.
Published: (2010-06-01)

CARDIORENAL RELATIONS AND QUALITY OF LIFE IN ELDERLY PATIENTS WITH CHRONIC HEART FAILURE IN LONG TERM THERAPY WITH CARVEDILOL AND BISOPROLOL
by: M. A. Statsenko, et al.
Published: (2015-12-01)

ROLE OF HYPERTENSION AND SUPRAVENTRICULAR ARRHYTHMIAS IN COGNITIVE IMPAIRMENTS: THE CURRENT PROBLEM STATE
by: N. N. Kriukov, et al.
Published: (2015-09-01)

ARRHYTHMIAS IN PREGNANT WOMEN — SIGNIFICANCE OF THE PROBLEM AND ITS SOLUTIONS
by: О. Е. Kolomatskaya, et al.
Published: (2016-03-01)

Genetic determinants of myocardial electric instability in patients with coronary heart disease undergoing endovascular intervention
by: Yu. I. Afanasiev, et al.
Published: (1970-01-01)

CLINICAL ASPECTS OF MYOCARDIAL ELECTRICAL INSTABILITY IN CHRONIC IHD
by: I. S. Karpova, et al.
Published: (2015-06-01)

Chronic heart failure in out-patient practice: aetiology issues
by: S. M. Bogdanova, et al.
Published: (2008-08-01)

Prognostic importance of dispersion of interval Q-T electrocardiograms in patients with myocardial infarction
by: A. T. Teplyakov, et al.
Published: (2006-03-01)

СЕРДЕЧНО-СОСУДИСТАЯ СИСТЕМА И ХРОНИЧЕСКАЯ БОЛЕЗНЬ ПОЧЕК
by: Х. Х. Шугушев, et al.
Published: (2012-04-01)

Ventricular arrhythmias in ischemic versus nonischemic chronic heart failure. Is the equal sign between arrhythmia mechanisms and treatment strategies applicable?
by: R. D. Kurbanov, et al.
Published: (2011-03-01)

Effusive pericarditis in the pathogenesis of cardiac arrhythmias in COVID-19: a case series
by: Z. N. Sukmarova, et al.
Published: (2022-02-01)

Роль эпикардиальной жировой ткани и автономной нервной системы в патогенезе нарушений ритма сердца
by: Д. Лосик, et al.
Published: (2021-09-01)

ADDITIONAL USE OF TRIMETAZIDINE IN PATIENTS WITH CHRONIC HEART FAILURE. A META-ANALYSIS
by: Lei Zhang, et al.
Published: (2015-12-01)

Fosinopril – a drug of choice in chronic heart failure prevention and treatment
by: N. Yu. Khosyainova, et al.
Published: (2006-08-01)

ENDOTHELIAL ADHESIVE FUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE COMPLICATED BY CHRONIC HEART FAILURE AND ATRIAL FIBRILLATION
by: A. N. Zakirova, et al.
Published: (2015-09-01)

SECONDARY PHARMACOLOGICAL PREVENTION OF CARDIOVASCULAR DISEASES: OUR ABILITY IN CLINICAL PRACTICE
by: E. V. Filippov, et al.
Published: (2015-12-01)

Clinical efficacy of nebivolol and metoprolol in complex treatment of patients with coronary heart disease and II-III functional class chronic heart failure
by: A. G. Evdokimova, et al.
Published: (2005-04-01)

The Relevance of Assessment of Nutritional Status in Children with Chronic Heart Failure
by: L. A. Gandaeva, et al.
Published: (2016-01-01)

EARLY MARKERS OF PROGRESSION OF HEART FAILURE AND APOPTOSIS: THEIR ROLE IN PREDICTING THE RISK OF ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH PRIOR MYOCARDIAL INFARCTION
by: A. T. Teplyakov, et al.
Published: (2016-03-01)

Positive effect of if-channel’s blocker ivabradine therapy in a patient with ischemic chronic heart failure with preserved left ventricle ejection fraction and hereditary thrombophilia (clinical case)
by: Iurii N. Belenkov, et al.
Published: (2019-09-01)

THE POSSIBILITY OF USAGE OF METABOLIC CORRECTION THERAPY IN PATIENTS WITH ISCHEMIC HEART DISEASE AND HEART FAILURE
by: I. V. Sergienko, et al.
Published: (2015-12-01)

New options in the treatment of patients with diabetes and heart failure. Generalized Russian experience
by: А. S. Ametov, et al.
Published: (2016-12-01)

ПЕРСПЕКТИВЫ РАЗВИТИЯ МЕТОДА НИЗКОВОЛЬТАЖНОЙ ДЕФИБРИЛЛЯЦИИ СЕРДЦА ДЛЯ КУПИРОВАНИЯ ПРЕДСЕРДНЫХ И ЖЕЛУДОЧКОВЫХ ТАХИАРИТМИЙ
by: A. G. Strelnikov, et al.
Published: (2015-10-01)

КОМБИНИРОВАННАЯ ТЕРАПИЯ АНТИТАХИКАРДИТИЧЕСКОЙ СТИМУЛЯЦИЕЙ И НИЗКОЭНЕРГЕТИЧЕСКИМ ШОКОМ У ПАЦИЕНТОВ С ЖЕЛУДОЧКОВОЙ ТАХИКАРДИЕЙ
by: А. Г. Стрельников, et al.
Published: (2015-10-01)